EVICEL Fibrin Sealant (Human): payments to doctors
Payments that named EVICEL Fibrin Sealant (Human) as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $651K
- Providers
- 1,319
- Transactions
- 2,227
- Average per transaction
- $292
The per-transaction average — $292 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,319 providers the average total is $493, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medical Device Business Services, Inc. | $468,171 | 71.9% |
| Johnson & Johnson | $181,887 | 27.9% |
| Johnson And Johnson International | $859 | 0.1% |